SCHEMBL16373177

SCHEMBL16373177

CCCN1CCc2c(n(CCCN3CCN(CCCN(CC(C)C)CC(C)C)CC3)c3ccccc23)C1c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.41
▸ ABCG2 Q9UNQ0 1/20 0.41
▸ SIGMAR1 Q99720 7/20 0.40
▸ DRD3 P35462 3/20 0.36
▸ DRD2 P14416 3/20 0.36
▸ BACE1 P56817 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ CHRM5 P08912 1/20 0.36
▸ ADRA2A P08913 1/20 0.36
▸ ADRA2B P18089 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ CHRM3 P20309 1/20 0.36
▸ DRD4 P21917 1/20 0.36
▸ SLC6A2 P23975 1/20 0.36
▸ HRH2 P25021 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ AVPR2 P30518 1/20 0.36
▸ ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16340546 0.76 SIGMAR1 (0.71) ABCB1ABCG2SIGMAR1BACE1ADRA1A
SCHEMBL16373144 0.74 ABCB1 (0.47) ABCB1ABCG2SIGMAR1DRD2HTR5A
SCHEMBL16373181 0.73 MAOA (0.63) DRD3DRD2CHRM2HTR1ACHRM5
SCHEMBL16373180 0.68 AKR1B10 (0.44) DRD3DRD2CHRM2HTR1ACHRM5
SCHEMBL16340059 0.65 SIGMAR1 (0.77) ABCB1ABCG2SIGMAR1ADRA1A
SCHEMBL2443854 0.65 CXCR4 (0.54) BACE1MEN1KMT2A
SCHEMBL20135920 0.64 SIGMAR1 (0.65) ABCB1ABCG2SIGMAR1
SCHEMBL17782062 0.63 SIGMAR1 (0.64) SIGMAR1HTR1A
SCHEMBL17782052 0.63 SIGMAR1 (0.71) ABCB1ABCG2SIGMAR1ADRA1A
SCHEMBL2444796 0.63 BACE1 (0.48) BACE1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014207241-A1 NEW Na-SUBSTITUTED CARBOLINE COMPOUNDS USABLE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES ALZPROTECT (FR) 2014-12-31 — — WO disclosed
Send feedback